Accueil Ernstrade Bourse Actualite Stock


Place: Copenhagen Stock Exchange

Exiqon A/S is a Denmark-based company active in the pharmaceutical industry. Its business is based on the proprietary Locked Nucleic Acids (LNA) technology. This technology offers advantages for life science researchers, drug developers and cancer treating physicians working towards personalizing treatment. The Company operates through three business area: Life Sciences which develops, markets, and sells research products for the analysis of miRNA molecules which can reveal a specific genetic profile; Diagnostics which provides of cellular based diagnostic tests for Extreme Drug Resistance, and Pharma Services which collaborates with pharmaceutical companies working for personalized medicine. Exiqon has entered into partnerships with Roche Applied Sciences, Life Technologies (ABI) and Luminex.



Copyright   2010